Prior to joining the firm, Mr. Chaput held the position of Regulatory Counsel at FDA's Center for Tobacco Products (CTP), where he analyzed industry submissions for compliance with FDA advertising laws and worked on retailer compliance and enforcement matters with respect to sales of tobacco products.
While in law school, Mr. Chaput served as a law clerk in the Federal Trade Commission, Bureau of Consumer Protection.
•Jul 31, 2017 FDA's New Tobacco Strategy: What Does It Mean for Your Vape Business?
•May 02, 2017 FDA Delays Upcoming Deeming Compliance Deadlines by Three Months; Sign Up for our FDA Compliance Webinar on May 9, 2017
•Jan 27, 2017 FDA Finalizes New Rule Clarifying When a Tobacco Product is Actually a Medical Product
•Dec 29, 2016 FDA's Ingredient Listing Deadline Rapidly Approaching for Manufacturers of E-Vapor, E-Liquid and Other Deemed Tobacco Products
•Dec 15, 2016 FDA's Establishment Registration and Product Listing Deadline is Fast Approaching - Are You Prepared?
•Feb 06, 2018 Keller and Heckman LLP Announces its Newest Law Blog for Vapor, Tobacco and Reduced-Harm Product Companies: The Continuum of Risk
•Oct 27, 2016 Azim Chowdhury to Moderate Panel at FDLI Tobacco Conference
•Sep 01, 2016 Azim Chowdhury Co-Authors FDLI's Guide Tobacco and Nicotine Delivery: Regulation and Compliance
•American Bar Association
You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.